Vaccinex, Inc.
VCNX
$0.72
-$0.02-2.70%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -18.63M | -18.58M | -17.76M | -19.19M | -20.25M |
| Total Depreciation and Amortization | 94.00K | 104.00K | 111.00K | 115.00K | 119.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 251.00K | -1.76M | -2.89M | -2.80M | -1.57M |
| Change in Net Operating Assets | 2.10M | 237.00K | 660.00K | 904.00K | 318.00K |
| Cash from Operations | -16.19M | -19.99M | -19.88M | -20.97M | -21.38M |
| Capital Expenditure | -22.00K | -22.00K | -32.00K | -18.00K | -67.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -22.00K | -22.00K | -32.00K | -18.00K | -67.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -76.00K | -75.00K | -62.00K | -74.00K | -74.00K |
| Issuance of Common Stock | 13.05M | 9.75M | 11.10M | 15.21M | 12.27M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | 1.70M | 1.70M | 1.70M | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 1.11M | 11.42M | 5.50M | 5.50M | 4.39M |
| Cash from Financing | 15.78M | 22.79M | 18.24M | 20.64M | 16.59M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -428.00K | 2.78M | -1.68M | -351.00K | -4.86M |